Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb 22:7:e31019.
doi: 10.7554/eLife.31019.

GRAM domain proteins specialize functionally distinct ER-PM contact sites in human cells

Affiliations

GRAM domain proteins specialize functionally distinct ER-PM contact sites in human cells

Marina Besprozvannaya et al. Elife. .

Abstract

Endoplasmic reticulum (ER) membrane contact sites (MCSs) are crucial regulatory hubs in cells, playing roles in signaling, organelle dynamics, and ion and lipid homeostasis. Previous work demonstrated that the highly conserved yeast Ltc/Lam sterol transporters localize and function at ER MCSs. Our analysis of the human family members, GRAMD1a and GRAMD2a, demonstrates that they are ER-PM MCS proteins, which mark separate regions of the plasma membrane (PM) and perform distinct functions in vivo. GRAMD2a, but not GRAMD1a, co-localizes with the E-Syt2/3 tethers at ER-PM contacts in a PIP lipid-dependent manner and pre-marks the subset of PI(4,5)P2-enriched ER-PM MCSs utilized for STIM1 recruitment. Data from an analysis of cells lacking GRAMD2a suggest that it is an organizer of ER-PM MCSs with pleiotropic functions including calcium homeostasis. Thus, our data demonstrate the existence of multiple ER-PM domains in human cells that are functionally specialized by GRAM-domain containing proteins.

Keywords: ER-PM contact sites; GRAMD proteins; PIP lipids; cell biology; cortical ER; human; membrane contact site; store operated calcium entry.

PubMed Disclaimer

Conflict of interest statement

MB, ED, HL, KG, DB No competing interests declared, JA Scientific advisory board, Mitobridge. JN Jodi Nunnari: Scientific advisory board, Mitobridge.

Figures

Figure 1.
Figure 1.. Defining a new family of human ER MCS proteins.
(A) Human proteins GRAMD1a-c and GRAMD2a and b are members of a protein family with similarity to the yeast Ltc1/Lam proteins, which all possess an unstructured N-terminus, a GRAM domain, and an ER-anchoring hydrophobic transmembrane domain. GRAMD1a-c contain an additional predicted sterol transport START-like VaST domain, similar to yeast family member Ltc1/Lam6. (B) Alignment of conserved GRAM domains from yeast and human family members. (C–D) Localization of GRAMD1a-eGFP (C) and GRAMD2a-eGFP (D) in COS7 mammalian cells relative to ER-marker mCherry-Sec61β and PM-marker lyn-mCherry. (E–F) Examination of localization of GRAMD1aΔGRAM (E) and GRAMD2aΔGRAM (F) with mCherry-Sec61β. Representative images shown from at least 17 cells that were obtained from three biological replicates. Scale bar 10 μm in full images and 5 μm in insets (the same dimensions are maintained for all subsequent figures).
Figure 1—figure supplement 1.
Figure 1—figure supplement 1.. GRAMD1a and GRAMD2a localize to ER-PM contact sites.
(A) Maximum Likelihood phylogenetic tree (bootstrapped 1000 times) of proteins possessing GRAM domains and PH domains from Homo sapiens, Saccharomyces cerevisiae, and Drosophila melanogaster. Phylogenetic analysis and structure prediction programs reveal that Ltc1-4 (Lam6/5/4 and Ysp2) and GRAMD1a-c as well as GRAMD2a and GRAMD2b are orthologs of a family of proteins that is anchored by the presence of a GRAM domain. MEGA7 software was used to generate this phylogenetic tree, which reveals that the GRAMD domains from H. sapiens proteins GRAMD1a/b/c, GRAMD2a, and GRAMD2b share a common ancestor with their S. cerevisiae protein orthologs Ltc1/2/3/4 (Lam6/5/4 and Ysp2). GRAMD4 is not evolutionarily related to GRAMD1a-c, GRAMD2a, or GRAMD2b. (B–C). Orthogonal view of GRAMD1a (B) or GRAMD2a (C) reconstructed from Z-stack of Cos7 cells expressing both lyn-mCherry, and BFP-Sec61β shown in Figure 1C and D. (D–E). TIRF imaging of Cos7 cells expressing either GRAMD1a-eGFP (D) or GRAMD2a-eGFP (E), lyn-mCherry, and BFP-Sec61β. Line scans demonstrate that GRAMD1a and GRAMD2a localize to regions of cortical ER at PM contacts. Y-axis of line scans are arbitrary fluorescence units. Representative images shown from at least 12 cells that were obtained from three biological replicates.
Figure 2.
Figure 2.. GRAMD2a and GRAMD1a mark distinct ER-PM contact sites.
(A) Analysis of the relative localization of GRAMD1a-eGFP and GRAMD2a-mCherry in Cos7 cells. Two sample cells are shown. Bottom panel is quantification of the amount of overlapping total fluorescence signal pixels from GRAMD1a-eGFP and GRAMD2a-mCherry. Representative images of two different cells, that were imaged on two different days shown. 14 cells imaged and analyzed from three biological replicates. (B–C) Localization of GRAMD2a-eGFP (B) or GRAMD1a-eGFP (D) relative to mCherry-labeled ER-PM tethers E-Syt2 or E-Syt3 in Cos7 cells. Bottom panels are line scan analysis of individual GRAMD2a-eGFP (B) or GRAMD1a-eGFP (C) foci. Y-axis of line scans are arbitrary fluorescence units. (D) Quantification of co-localization of GRAMD2a or GRAMD1a with E-Syt2 and E-Syt3 as % of total fluorescence pixels of GRAMD1a or GRAMD2a (top panel) or ESyt2 or ESyt3 (bottom panel). Standard Error shown, *p<10−2 from two-tailed t-test. Specifically, GRAMD2a with E-Syt2 compared to GRAMD1a with E-Syt2, p=8.97 × 10−12; GRAMD2a with E-Syt3 compared to GRAMD1a with E-Syt3, p=3.40 × 10−17; E-Syt2 with GRAMD2a compared to E-Syt2 with GRAMD1a, p=9.56 × 10−7; E-Syt3 with GRAMD2a compared to E-Syt3 with GRAMD1a, p=3.14 × 10−13. Representative images shown from at least 16 cells that were obtained from three biological replicates. Pixel co-localization analysis was performed on all cells.
Figure 2—figure supplement 1.
Figure 2—figure supplement 1.. Relationship of GRAMD1a and GRAMD2a to E-Syt2/3.
(A–B) TIRF imaging of Cos7 cells expressing GRAMD2a-eGFP with mCherry-E-Syt2 (A) or mCherry-E-Syt3 (B) and BFP-Sec61β. (C) Localization of GRAMD2a-eGFP in wild type HeLa cells and HeLa E-Syt1/2/3 -/- cells (Saheki et al., 2016). (D–E). TIRF imaging of Cos7 cells expressing GRAMD1a-eGFP with mCherry-E-Syt2 (D) or E-Syt3-mCherry (E), and BFP-Sec61β. Bottom panels of A-B and D-E are line scans of fluorescence associated with GRAMD2a and GRAMD1a fluorescent foci. Y-axis of line scans are arbitrary fluorescence units. Representative images shown from at least 10 cells that were obtained from two biological replicates.
Figure 3.
Figure 3.. Gene set enrichment analysis of GRAMD1a and GRAMD2a indicated distinct physiological functions.
(A) Comparison of enrichment results between GRAMD1a and GRAMD2a in transcriptome data of liver samples from 193 female human individuals. Normalized enrichment score (NES) of GRAMD1a and GRAMD2a are used to compare the GO pathway enrichment of these two genes in lipid metabolism and Ca2+ signaling gene sets highlighted in green and blue, respectively. Dot size represents the number of genes, and transparency of the dot indicates the significance (-log10(nominal p value)) of the enrichment of the two transcripts for the gene set. (B) Heat-map showing the enrichment of GRAMD1a and GRAMD2a in genes involved in lipid metabolism and Ca2+ signaling in liver samples from human male and female individuals, as well as from males of the BXD mouse genetic reference population. (C–D) Enrichment plot of GRAMD1a and GRAMD2a in human liver samples from female individuals shows their distinct physiological functions in lipid metabolism (C) and Ca2+ signaling pathways (D). FDR, false discovery rate.
Figure 3—figure supplement 1.
Figure 3—figure supplement 1.. Gene set enrichment analysis of GRAMD1a and GRAMD2a in males.
(A) Comparison of enrichment results between GRAMD1a and GRAMD2a in transcriptome data of liver samples from 234 male humans. Normalized enrichment score (NES) of GRAMD1a and GRAMD2a are used to compare the GO pathway enrichment of these two genes in lipid metabolism and Ca2+ signaling gene sets highlighted in green and blue, respectively. Dot size represents the number of genes, and transparency of the dot indicates the significance (-log10(nominal p value)) of the enrichment of the two transcripts for the gene set. (C–D) Enrichment plot of GRAMD1a and GRAMD2a in human liver samples from male individuals shows their distinct physiological functions in lipid metabolism (B) and calcium signaling pathways (C). FDR, false discovery rate.
Figure 4.
Figure 4.. GRAMD2a is targeted to the PM via PI(4,5)P2.
(A–B) Examination of the PI(4,5)P2-dependent behavior of PM-associated GRAMD2a-eGFP (A) and GRAMD1a-eGFP (B). PM PI(4,5)P2 was reversibly depleted by 10 s addition (middle panel) and removal (left panel) of 10 μM of the muscarinic agonist oxotremorineM (OxoM) as monitored by the PI(4,5)P2 marker CFP-PH-PLCδ1. Normalized intensity of fluorescent proteins used in PI(4,5)P2 depletion experiments shown in lower panels of (A and B). Representative images shown from at least 12 cells that were obtained from two biological replicates. Fluorescence intensity dynamics were analyzed for all cells. (C) Western Blot analysis of centrifugation-based liposome binding assays with recombinant His6-GRAMD2aΔTM and liposomes of different composition. Control PM-like liposomes: 85% PC: 15% PS; PM-like liposomes with PI: 85% PC: 10% PS: 5% PI or 85% PC: 15% PI; PM-like liposomes with PI(4)P: 85% PC: 14% PS: 1% PI(4)P, 85% PC: 10% PS: 5% PI(4)P, or 85% PC: 15% PI(4)P; PM-like liposomes with PI(4,5)P2: 85% PC: 14% PS: 1% PI(4,5)P2, 85% PC: 10% PS: 5% PI(4,5)P2, or 85% PC: 15% PI(4,5)P2. S and P indicate supernatant and pellet, respectively. (D) Quantification of liposome binding experiments, n = 4 (biological replicates), Standard Error shown.
Figure 4—figure supplement 1.
Figure 4—figure supplement 1.. Schematic depiction of liposome binding assays.
A. Recombinant GRAMD2aΔTM was incubated with liposomes and ultracentrifugation was used to separate liposome-protein complexes from free protein.
Figure 5.
Figure 5.. GRAMD2a pre-marks ER-PM membrane contact sites used for STIM1 recruitment during SOCE.
(A) Cortical ER as visualized with ER marker GFP-Sec61β in cells overexpressing GRAMD2a-mCherry (top panel) or mCherry-STIM1 (bottom panel). (B) Behavior of mCherry-STIM1 at resting Ca2+ and upon depletion of Ca2+ stores from the ER using SERCA inhibitor thapsigargin (TG). At T = 30 s, 1 μM TG was added. Two representative cells shown from two different experimental days. Lower panel left shows sample graph of total fluorescence of GRAMD2a-eGFP and mCherry-STIM1 throughout duration of experiment for a sample cell. (C) Zoomed-in images and line scans of individual GRAMD2a fluorescent puncta and associated fluorescence for duration of the TG treatment. Left and right panels are examples of puncta from two different cells. Y-axis of line scans are arbitrary fluorescence units. Scale bar is 2 μm. (D) Inset cropped from top cell in (B). showing COS7 cell expressing GRAMD2a-eGFP, mCherry-STIM1, and BFP-Sec61β at T300s of the TG-stimulated Ca2+ depletion. Corresponding zoomed-in images and line-scans are shown in the bottom panel. Representative images shown from at least 19 cells that were obtained from three biological replicates.
Figure 5—figure supplement 1.
Figure 5—figure supplement 1.. Supporting evidence for STIM1 recruitment to GRAMD2a-marked ER-PM contact sites.
(A) Western Blot analysis of GRAMD2a-eGFP and GRAMD1a-eGFP (α-GFP) in Cos7 and U2OS cells transfected with low (0.1 μg) and high (1 μg) amounts of plasmids expressing GRAMD2a-eGFP and GRAMD1a-eGFP. α-GAPDH is loading control. Three biological triplicates of western blot analysis were performed. (B) High level of expression of GRAMD1a-mCherry (1 μg of DNA per 35 mm MatTeck dish transfected) and eGFP-Sec61β. Representative images shown from 11 cells that were obtained from three biological replicates C) Four additional examples of individual GRAMD2a-eGFP puncta and associated line scans during time-lapse experiments of TG-treated Cos7 cells transfected with GRAMD2a-eGFP and mCherry-STIM1. Pucta were selected from 19 cells that were imaged on three different days. Y-axis of line scans are arbitrary fluorescence units. (D). Images of cells expressing GRAMD1a-eGFP or GRAMD2a-eGFP (duplicated from Figure 5B – top cell) at T = 300 s following TG treatment. Quantification of total signal overlap between STIM1 and either GRAMD2a or GRAMD1a after TG-induced Ca2+ depletion (right panel). Standard Error shown, *p<10−2 from two-tailed t-test. Specifically, GRAMD2a with STIM1 compared to GRAMD1a with STIM1, p=4.02 × 10−13; STIM1 with GRAMD2a compared to STIM1 with GRAMD1a, p=5.00 × 10−6. Representative images shown from at least 19 cells that were obtained from three biological replicates.
Figure 6.
Figure 6.. STIM1ΔK is defective for targeting to PI(4,5)P2-enriched ER-PM contact sites marked by GRAMD2a.
(A–C) Fluorescence images of Cos7 cells expressing mCherry-STIM1ΔK, a PI(4,5)P2-insensitive mutant, and either (A) GRAMD2a-eGFP or (C) GRAMD1a-eGFP before and after TG treatment along with (B) quantification of co-localization. Standard Error shown, *p<10−2 and p>10−2 from two-tailed t-test. Specifically, GRAMD2a with STIM1 compared to GRAMD2a with STIM1ΔK, p=4.47 × 10−12; GRAMD1a with STIM1 compared to GRAMD1a with STIM1ΔK, p=2.70 × 10−2; STIM1 with GRAMD2a compared to STIM1 with GRAMD1a, p=5.00 × 10−6; STIM1ΔK with GRAMD2a compared to STIM1ΔK with GRAMD1a, p=3.64 × 10−1. Representative images shown from at least 14 cells that were obtained from three biological replicates. Pixel co-localization analysis was performed on all cells.
Figure 6—figure supplement 1.
Figure 6—figure supplement 1.. STIM1ΔK does not respond to TG in HeLa cells.
(A) HeLa cells expressing mCherry-STIM1 (top panel) and mCherry-STIM1ΔK (bottom panel) before and after TG treatment to deplete ER Ca2+.
Figure 7.
Figure 7.. GRAMD2a organizes ER-PM domains that selectively function in calcium homeostasis.
(A) Kinetics and intensity of mCherry-STIM1 recruitment to PM before, during, and after 1 uM TG treatment in wildtype U2OS cells, GRAMD2a knock out (KO) cells, and GRAMD2a KO with GRAMD2a-eGFP transiently transfected. Standard Error is shown, p<0.05 between t = 200 and t-600. (B) Cytosolic Ca2+ measurement using ratiomentric dye, Fura-PE3 AM during a Ca2+ addback experiment with wild type U2OS cells and GRAMD2a KO cells. Cells were pre-loaded with 2.5 uM Fura-PE3 AM in 0 mM Ca2+ Ringers and ER stores were loaded in 2 mM Ca2+ Ringers for 4 min prior to recording. Fluorescence was continuously recorded as cells were incubated in the following solutions: (1) Baseline was established in 2 mM Ca2+ ringers for 40 s, (2) cells were washed with 0 mM Ca2+/2 mM EGTA Ringers for 100 s, 3) ER stores were emptied using 4 uM TG in 0 mM Ca2+/2 mM EGTA Ringers for 460 s, 4) cells were returned to with 0 mM Ca2+/2 mM EGTA Ringers for 100 s, (5) cells were washed in 2 mM Ca2+ ringers to observe SOCE across the PM. Comparison of the cytosolic Ca2+ measurements (represented as Fura-PE3 Am ratio) are shown over time. Black trace represented control or wild type U2OS cells; red trace represents GRAMD2a KO U2OS cells. Standard Error is shown, differences between wild type and GRAMD2a traces were not statistically significant as determined using student t-test. nine wild type dishes and 8 GRAMD2a KO dishes were imaged over 2 days. 20–50 cells per dish were imaged. (C) Localization of mCherry-E-Syt2 (left panel) or E-Syt3-mCherry (right panel) in wild type U2OS and GRAMD2a KO cells. (D) Behavior of mCherry-E-Syt1 at resting Ca2+ and upon TG-induced ER Ca2+ depletion. At T = 30 s, 1 μM TG was added. Top panels show mCherry-E-Syt1 dynamics in wild type U2OS cells and bottom panels show mCherry-E-Syt1 dynamics in GRAMD2a KO cells. For STIM1 and E-Syt1/2/3 experiments, fluorescence intensity dynamics were analyzed for at least 12 cells, where were imaged in biological duplicate.
Figure 7—figure supplement 1.
Figure 7—figure supplement 1.. STIM1 recruitment is altered in GRAMD2a KO cells.
(A) Alignment of GRAMD2a CRISPR knock-out (KO) and wild type sequence. (B) Samples images of wildtype U2OS, GRAMD2a KO, and GRAMD2a KO with GRAMD2a-eGFP transiently transfected cells that were quantified in Figure 7A. Representative images shown from at least 12 cells that were obtained from two biological replicates. (C) Size and total number of mCherry-STIM1 puncta in wild type and GRAMD2a KO cells. Standard Error shown, *p<10−2 and from two-tailed t-test. Specifically, puncta size p=2.2 × 10−3. (D) Western Blot analysis of endogenous STIM1 protein levels in wild type U2OS cells and GRAMD2a KO cells. α-GAPDH is loading control. Three biological triplicates of western blot analysis were performed. (E) Western Blot analysis of mCherry-STIM1 and mCherry-E-Syt1 protein levels in wild type U2OS cells and GRAMD2a KO cells. α-GAPDH is loading control. Three biological triplicates of western blot analysis were performed.
Figure 7—figure supplement 2.
Figure 7—figure supplement 2.. PM PI(4,5)P2, cholesterol and caveolin-1 are not apparently altered in GRAMD2a KO cells.
(A) TIRF imaging of BFP-Sec61β and lyn-mCherry in WT U2OS cells and GRAMD2a KO cells. Total pixels of cortical ER were divided by total area of cells, judged by total staining of lyn-mCherry, to determine % cortical ER at PM. Standard Error shown. (B) PM PI(4,5)P2 distribution was examined using YFP-PH-PLCδ1 in U2OS wild type and GRAMD2a KO cells. Sample images are in shown in left panel. Line scans are shown in middle panel. Y-axis of line scans are arbitrary fluorescence units. % intensity of YFP-PH-PLCδ1 at PM is shown in right panel. (C) Distribution of cholesterol marker mCherry-D4H in wild type U2OS and GRAMD2a KO cells. Line scans are shown in bottom panel. Y-axis of line scans are arbitrary fluorescence units. (D) Distribution of cholesterol-binding protein Cav1-GFP in wild type U2OS and GRAMD2a KO cells. Both PM (cell surface) and internal (cross-section) planes are shown.
Figure 7—figure supplement 3.
Figure 7—figure supplement 3.. E-Syt1 localization is altered in GRAMD2a KO cells.
(A) mCherry-E-Syt1 distribution in three additional representative wild type U2OS cells and GRAMD2a KO cells at T = 0 (pre-TG treatment) and T = 250 (220 sec after TG treatment). (B) mCherry-E-Syt1 distribution in wild type U2OS and GRAMD2a KO cells after incubation in 20 min 2 mM EGTA Ringers to ensure chelation of all external Ca2+. Representative images shown from at least 12 cells that were obtained from two biological replicates.
Figure 8.
Figure 8.. Model of GRAMD2a function.
GRAMD2a is a constitutive PI(4,5)P2-dependent ER-PM tether that localizes to a subset of E-Syt2/3 contacts. GRAMD1a marks distinct ER-PM contacts in a PI(4,5)P2-independent manner. GRAMD2a pre-marks ER-PM contacts destined for SOCE and facilitates, STIM1 recruitment during SOCE.
Figure 8—figure supplement 1.
Figure 8—figure supplement 1.. GRAMD1a localization is cell line dependent.
(A) Localization of GRAMD1a-eGFP in COS7, U2OS, and Arpe19 cells relative to ER-marker BFP-Sec61β. Representative images shown from at least 10 cells that were obtained from three biological replicates.

Comment in

References

    1. Begley MJ, Taylor GS, Kim SA, Veine DM, Dixon JE, Stuckey JA. Crystal structure of a phosphoinositide phosphatase, MTMR2: insights into myotubular myopathy and Charcot-Marie-Tooth syndrome. Molecular Cell. 2003;12:1391–1402. doi: 10.1016/S1097-2765(03)00486-6. - DOI - PubMed
    1. Berger P, Schaffitzel C, Berger I, Ban N, Suter U. Membrane association of myotubularin-related protein 2 is mediated by a pleckstrin homology-GRAM domain and a coiled-coil dimerization module. PNAS. 2003;100:12177–12182. doi: 10.1073/pnas.2132732100. - DOI - PMC - PubMed
    1. Bian X, Saheki Y, De Camilli P. Ca2+releases E-Syt1 autoinhibition to couple ER-plasma membrane tethering with lipid transport. The EMBO Journal. 2018;37:219–234. doi: 10.15252/embj.201797359. - DOI - PMC - PubMed
    1. Botelho RJ, Teruel M, Dierckman R, Anderson R, Wells A, York JD, Meyer T, Grinstein S. Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis. The Journal of Cell Biology. 2000;151:1353–1368. doi: 10.1083/jcb.151.7.1353. - DOI - PMC - PubMed
    1. Carrasco S, Meyer T. STIM proteins and the endoplasmic reticulum-plasma membrane junctions. Annual Review of Biochemistry. 2011;80:973–1000. doi: 10.1146/annurev-biochem-061609-165311. - DOI - PMC - PubMed

Publication types